½ÃÀ庸°í¼­
»óǰÄÚµå
1594024

ÀÇ·á¿ë ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¼ÒÇÁÆ®¿þ¾î, ¿µ»ó À¯Çü, ¸ð´Þ¸®Æ¼, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Medical Image Analysis Software Market by Software (Integrated Software, Standalone Software), Image Type (2D Imaging, 2D Imaging, 3D Imaging), Modality, Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 189 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÇ·á¿ë ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ 2023³â ½ÃÀå ±Ô¸ð´Â 36¾ï 6,000¸¸ ´Þ·¯·Î, 2024³â¿¡´Â 40¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 9.80%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 70¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÇ·á ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î´Â Áø´Ü Á¤È®µµ Çâ»ó°ú Ä¡·á °èȹ ¼ö¸³¿¡ ÇʼöÀûÀ̸ç, CT, MRI, X-·¹ÀÌ ½ºÄµ µî ÀÇ·á ¿µ»óÀ» ó¸®Çϰí ÇØ¼®ÇÏ´Â °í±Þ ÅøÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ»ó °¨Áö ¹× ºÐ¼®, ¼ö¼ú °èȹ Áö¿ø, ¸ÂÃãÇü ÀÇ·á ÃËÁø µî ±× ¹üÀ§´Â ¸Å¿ì ±¤¹üÀ§ÇÕ´Ï´Ù. ÀÌ ¼ÒÇÁÆ®¿þ¾îÀÇ Çʿ伺Àº ¸¸¼ºÁúȯ Áõ°¡¿Í µðÁöÅÐ °Ç°­ ½Ã½ºÅÛÀÇ ±¤¹üÀ§ÇÑ µµÀÔÀ¸·Î ÀÎÇØ È¿À²ÀûÀÎ Áø´Ü ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °­Á¶µÇ°í ÀÖ½À´Ï´Ù. ¿ëµµ·Î´Â ¹æ»ç¼±°ú, ¼øÈ¯±â³»°ú, Á¾¾çÇаú, ½Å°æ°ú µîÀÇ ºÐ¾ß¿¡¼­ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëó´Â º´¿ø, Áø´Ü¼¾ÅÍ, ¿¬±¸ ±â°ü µî ´Ù¾çÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023] 36¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â[2024] 40¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø³â[2030] 70¾ï 6,000¸¸ ´Þ·¯
CAGR(%) 9.80%

ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â À̹ÌÁö ÆÇµ¶ÀÇ Á¤È®¼º°ú ¾÷¹« È¿À²¼ºÀ» ³ôÀÌ´Â AI ÅëÇÕ ¹× ¸Ó½Å·¯´×°ú °°Àº ±â¼ú ¹ßÀüÀÌ ÀÖ½À´Ï´Ù. ÇコÄɾîÀÇ µðÁöÅÐÈ­¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ °ü½Éµµ ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀº È®À强ÀÌ ¶Ù¾î³ª°í ¿ø°ÝÀÇ·á µ¿Çâ¿¡ ºÎÇÕÇÏ¿© ¿ø°ÝÁö¿¡¼­µµ Á¢±ÙÀÌ °¡´ÉÇÕ´Ï´Ù. ½ÅÈï ±¹°¡ ½ÃÀåÀ» °ø·«Çϱâ À§ÇØ ±â¾÷Àº ±ÔÁ¦ Ç¥ÁØÀ» ÁؼöÇÏ°í »ç¿ëÀÚ Ä£È­ÀûÀÌ¸ç »óÈ£ ¿î¿ë °¡´ÉÇÑ ¼ÒÇÁÆ®¿þ¾î °³¹ß¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù.

±×·¯³ª ³ôÀº Ãʱ⠺ñ¿ë, ÀáÀçÀûÀÎ µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã ¹®Á¦, ÷´Ü ½Ã½ºÅÛ ¿î¿µÀ» À§ÇÑ ¼÷·ÃµÈ ÀηÂÀÇ Çʿ伺 µîÀº ¼Ò±Ô¸ð ÀÇ·á ±â°ü¿¡ À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ±ÔÁ¦ À庮°ú °³¹ßµµ»ó±¹¿¡¼­ÀÇ ´À¸° º¸±Þ·üµµ °É¸²µ¹·Î ÀÛ¿ëÇÕ´Ï´Ù. Çõ½ÅÀ» ÃËÁøÇϱâ À§ÇØ ±â¾÷Àº AI ±â¹Ý ºÐ¼®¿¡ ÅõÀÚÇϰí, 3D ¿µ»ó ±â¼úÀ» ޱ¸Çϰí, ´Ù¾çÇÑ ÀÇ·á Ç÷§Æû°úÀÇ ¼ÒÇÁÆ®¿þ¾î ȣȯ¼ºÀ» Çâ»ó½ÃÄÑ¾ß ÇÕ´Ï´Ù. »çÀ̹ö º¸¾È Á¶Ä¡¸¦ ¿ì¼±½ÃÇÏ¸é µðÁöÅÐ ¼Ö·ç¼Ç¿¡ ´ëÇÑ »ç¿ëÀÚÀÇ ½Å·Ú¸¦ ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.

ÀüüÀûÀ¸·Î ½ÃÀåÀº ºü¸¥ ±â¼ú ¹ßÀü°ú °æÀïÀÌ Æ¯Â¡À̸ç, ÀÌ´Â ¹Îø¼º°ú Çõ½ÅÀÌ ¼ºÀåÀ» À¯ÁöÇϱâ À§ÇÑ ÇÙ½É ¿ä¼ÒÀÓÀ» ½Ã»çÇÕ´Ï´Ù. Àü·«Àû ÆÄÆ®³Ê½Ê°ú Çù·Â °ü°è´Â »õ·Î¿î ±æÀ» ¿­¾î ´õ ³ÐÀº ½ÃÀå ÁøÀÔÀ» ¿ëÀÌÇÏ°Ô Çϰí, ¿ªµ¿ÀûÀÎ ÇコÄɾî ȯ°æ¿¡¼­ ÀûÀÀ·ÂÀ» È®º¸ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ÀÇ·á ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÇ·á ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Àü ¼¼°è ¸¸¼ºÁúȯÀÇ È®»ê
    • ÄÄÇ»ÅÍ Áö¿ø Áø´ÜÀÇ Àû¿ë È®´ë
    • ÀÇ·á¿ë ¿µ»óó¸® ºÐ¾ß¿¡ ´ëÇÑ ¹Î°ü ÅõÀÚ È®´ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·°ú ÇÑÁ¤µÈ ¿¹»ê
  • ½ÃÀå ±âȸ
    • À̹ÌÁö ºÐ¼® ¼ÒÇÁÆ®¿þ¾î¿¡ AI ¹× ±âŸ ±â¼ú ÅëÇÕ
    • Ŭ¶ó¿ìµå ±â¹Ý À̹ÌÁö ºÐ¼® ¼Ö·ç¼ÇÀÇ Áö¼ÓÀûÀÎ µµÀÔ
  • ½ÃÀå °úÁ¦
    • ¼ÒÇÁÆ®¿þ¾î »ç¿ëÀÇ º¸¾È ¹× °³ÀÎ Á¤º¸ º¸È£ ¹®Á¦

Portre's Five Forces: ÀÇ·á ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû Åø

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÇ·á ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÇ·á ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ÀǷ῵»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

ÀÇ·á ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû Æ÷Áö¼Å´×À» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ÀÇ·á ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÇ·á ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÇ·á ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

ÀÇ·á ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. :

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù. :

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ÀÇ·á¿ë ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ¼ÒÇÁÆ®¿þ¾î

  • ÅëÇÕ ¼ÒÇÁÆ®¿þ¾î
  • ½ºÅĵå¾ó·Ð ¼ÒÇÁÆ®¿þ¾î

Á¦7Àå ÀÇ·á¿ë ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ¿µ»ó À¯Çüº°

  • 2D À̹Ì¡
  • 2D À̹Ì¡
  • 3D À̹Ì¡

Á¦8Àå ÀÇ·á¿ë ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • º¹ÇÕ ¸ð´Þ¸®Æ¼
    • PET/CT
    • PET/MR
    • ½ºÆåÆ®·³ CT
  • ¹æ»ç¼± ¿µ»ó
  • ´ÜÃþÃÔ¿µ
    • ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT)
      • ÇÏÀÌ¿£µå ½½¶óÀ̽º CT
      • ·Î¿£µå ½½¶óÀ̽º CT
      • ¹Ìµå¿£µå ½½¶óÀ̽º CT
    • ÀÚ±â°ø¸í¿µ»ó
      • Æó¼âÇü MRI ½Ã½ºÅÛ
      • ¿ÀÇ MRI ½Ã½ºÅÛ
    • ¾çÀüÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ
    • ´ÜÀÏ ±¤ÀÚ ¹æÃâ ´ÜÃþÃÔ¿µ
  • ÃÊÀ½ÆÄ ¿µ»ó Áø´Ü
    • 2D ÃÊÀ½ÆÄ ½Ã½ºÅÛ
    • 3D ¹× 4D ÃÊÀ½ÆÄ ½Ã½ºÅÛ
    • µµÇ÷¯ ¿µ»ó

Á¦9Àå ÀÇ·á¿ë ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¿ëµµº°

  • ½ÉÀ庴ÇÐ ¾ÖÇø®ÄÉÀ̼Ç
  • Ä¡°ú ¿ëµµ
  • ¸¾¸ð±×·¡ÇÇÀÇ ÀÀ¿ë
  • ½Å°æÇÐ
  • »êºÎÀΰú ¾ÖÇø®ÄÉÀ̼Ç
  • Á¾¾çÇÐ ¾ÖÇø®ÄÉÀ̼Ç
  • Á¤Çü¿Ü°ú ¿ëµµ
  • ºñ´¢±â°ú ¹× ½ÅÀå°ú ¾ÖÇø®ÄÉÀ̼Ç

Á¦10Àå ÀÇ·á¿ë ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • Áø´Ü ¼¾ÅÍ
  • º´¿ø
  • ¿¬±¸ ¼¾ÅÍ

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÇ·á¿ë ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á¿ë ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á¿ë ¿µ»ó ºÐ¼® ¼ÒÇÁÆ®¿þ¾î ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • AnalyzeDirect Inc.
  • Aquilab SAS
  • Bruker Corporation
  • CANON MEDICAL SYSTEMS CORPORATION
  • Carestream Health, Inc.
  • ClaroNAv Inc.
  • Esaote SpA
  • Fujitsu Ltd.
  • GE Healthcare
  • International Business Machines Corp.
  • MIM Software Inc.
  • Mirada Medical Limited
  • Philips Healthcare
  • Sciencesoft USA Corporation
  • Siemens Healthcare
  • Xinapse Systems Ltd.
KSA 24.11.22

The Medical Image Analysis Software Market was valued at USD 3.66 billion in 2023, expected to reach USD 4.02 billion in 2024, and is projected to grow at a CAGR of 9.80%, to USD 7.06 billion by 2030.

Medical Image Analysis Software is essential for enhancing diagnostic precision and treatment planning, offering sophisticated tools for processing and interpreting medical images such as CT, MRI, and X-ray scans. Its scope includes aiding in the detection and analysis of abnormalities, aiding surgical planning, and fostering personalized medicine approaches. This software's necessity is underscored by the increasing demand for efficient diagnostic solutions, fueled by rising chronic disease prevalence and the broader adoption of digital health systems. In terms of application, the software finds usage across radiology, cardiology, oncology, and neurology, among other disciplines. The end-use scope spans hospitals, diagnostic centers, and research institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 3.66 billion
Estimated Year [2024] USD 4.02 billion
Forecast Year [2030] USD 7.06 billion
CAGR (%) 9.80%

Key growth factors include technological advances like AI integration and machine learning, which enhance image interpretation accuracy and operational efficiency. The increasing investment in healthcare digitization and emphasis on minimally invasive procedures also bolster market expansion. A significant potential opportunity lies in the growing preference for cloud-based solutions due to their scalability and remote accessibility, which aligns with telemedicine trends. Companies must focus on developing user-friendly, interoperable software that complies with regulatory standards to capture emerging markets.

However, challenges include high initial costs, potential data privacy issues, and the need for skilled personnel to operate advanced systems, which can be barriers for smaller institutions. Regulatory hurdles and the slow adoption rate in developing regions also present obstacles. To foster innovation, companies should invest in AI-driven analytics, explore 3D imaging techniques, and enhance software compatibility with various healthcare platforms. Prioritizing cybersecurity measures will enhance user trust in digital solutions.

Overall, the market is characterized by rapid technological evolution and competition, suggesting that agility and innovation are crucial for sustaining growth. Engaging in strategic partnerships and collaborations can open new avenues and facilitate broader market reach, ensuring adaptability in a dynamic healthcare environment.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Image Analysis Software Market

The Medical Image Analysis Software Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic diseases worldwide
    • Rising application of computer-aided diagnosis
    • Increasing public and private investments in medical imaging sector
  • Market Restraints
    • Lack of skilled professional and limited budget
  • Market Opportunities
    • Integration of AI and other technologies in imaging analysis software
    • Ongoing introduction of cloud-based image analysis solutions
  • Market Challenges
    • Concerns of security and privacy with software use

Porter's Five Forces: A Strategic Tool for Navigating the Medical Image Analysis Software Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Image Analysis Software Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Image Analysis Software Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Image Analysis Software Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Image Analysis Software Market

A detailed market share analysis in the Medical Image Analysis Software Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Image Analysis Software Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Image Analysis Software Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Image Analysis Software Market

A strategic analysis of the Medical Image Analysis Software Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Image Analysis Software Market, highlighting leading vendors and their innovative profiles. These include AnalyzeDirect Inc., Aquilab SAS, Bruker Corporation, CANON MEDICAL SYSTEMS CORPORATION, Carestream Health, Inc., ClaroNAv Inc., Esaote SpA, Fujitsu Ltd., GE Healthcare, International Business Machines Corp., MIM Software Inc., Mirada Medical Limited, Philips Healthcare, Sciencesoft USA Corporation, Siemens Healthcare, and Xinapse Systems Ltd..

Market Segmentation & Coverage

This research report categorizes the Medical Image Analysis Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Software, market is studied across Integrated Software and Standalone Software.
  • Based on Image Type, market is studied across 2D Imaging, 2D Imaging, and 3D Imaging.
  • Based on Modality, market is studied across Combined Modalities, Radiographic Imaging, Tomography, and Ultrasound Imaging. The Combined Modalities is further studied across PET/CT, PET/MR, and SPECT/CT. The Tomography is further studied across Computed Tomography (CT), Magnetic Resonance Imaging, Positron Emission Tomography, and Single-Photon Emission Tomography. The Computed Tomography (CT) is further studied across High-End Slice CT, Low-End Slice CT, and Mid-End Slice CT. The Magnetic Resonance Imaging is further studied across Closed MRI Systems and Open MRI Systems. The Ultrasound Imaging is further studied across 2D Ultrasound Systems, 3D & 4D Ultrasound Systems, and Doppler Imaging.
  • Based on Application, market is studied across Cardiology Applications, Dental Applications, Mammography Applications, Neurology, Obstetrics & Gynecology Application, Oncology Applications, Orthopedic Applications, and Urology & Nephrology Applications.
  • Based on End-User, market is studied across Diagnostic Centers, Hospitals, and Research Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic diseases worldwide
      • 5.1.1.2. Rising application of computer-aided diagnosis
      • 5.1.1.3. Increasing public and private investments in medical imaging sector
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled professional and limited budget
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of AI and other technologies in imaging analysis software
      • 5.1.3.2. Ongoing introduction of cloud-based image analysis solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns of security and privacy with software use
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Image Analysis Software Market, by Software

  • 6.1. Introduction
  • 6.2. Integrated Software
  • 6.3. Standalone Software

7. Medical Image Analysis Software Market, by Image Type

  • 7.1. Introduction
  • 7.2. 2D Imaging
  • 7.3. 2D Imaging
  • 7.4. 3D Imaging

8. Medical Image Analysis Software Market, by Modality

  • 8.1. Introduction
  • 8.2. Combined Modalities
    • 8.2.1. PET/CT
    • 8.2.2. PET/MR
    • 8.2.3. SPECT/CT
  • 8.3. Radiographic Imaging
  • 8.4. Tomography
    • 8.4.1. Computed Tomography (CT)
      • 8.4.1.1. High-End Slice CT
      • 8.4.1.2. Low-End Slice CT
      • 8.4.1.3. Mid-End Slice CT
    • 8.4.2. Magnetic Resonance Imaging
      • 8.4.2.1. Closed MRI Systems
      • 8.4.2.2. Open MRI Systems
    • 8.4.3. Positron Emission Tomography
    • 8.4.4. Single-Photon Emission Tomography
  • 8.5. Ultrasound Imaging
    • 8.5.1. 2D Ultrasound Systems
    • 8.5.2. 3D & 4D Ultrasound Systems
    • 8.5.3. Doppler Imaging

9. Medical Image Analysis Software Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiology Applications
  • 9.3. Dental Applications
  • 9.4. Mammography Applications
  • 9.5. Neurology
  • 9.6. Obstetrics & Gynecology Application
  • 9.7. Oncology Applications
  • 9.8. Orthopedic Applications
  • 9.9. Urology & Nephrology Applications

10. Medical Image Analysis Software Market, by End-User

  • 10.1. Introduction
  • 10.2. Diagnostic Centers
  • 10.3. Hospitals
  • 10.4. Research Centers

11. Americas Medical Image Analysis Software Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Medical Image Analysis Software Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Medical Image Analysis Software Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AnalyzeDirect Inc.
  • 2. Aquilab SAS
  • 3. Bruker Corporation
  • 4. CANON MEDICAL SYSTEMS CORPORATION
  • 5. Carestream Health, Inc.
  • 6. ClaroNAv Inc.
  • 7. Esaote SpA
  • 8. Fujitsu Ltd.
  • 9. GE Healthcare
  • 10. International Business Machines Corp.
  • 11. MIM Software Inc.
  • 12. Mirada Medical Limited
  • 13. Philips Healthcare
  • 14. Sciencesoft USA Corporation
  • 15. Siemens Healthcare
  • 16. Xinapse Systems Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦